Asbestos exposure in patients affected by bile duct tumours
Keywords:
asbestos, tumours, bile ductsAbstract
Aims. Exposure to asbestos represents an important risk factor for the onset of pleural and peritoneal mesothelioma. An association with gastrointestinal and bile duct adenocarcinoma may also be possible. Patients and methods. In 2007, 55 patients with bile duct neoplasm who were admitted to our centre were investigated extensively about their exposure to known risk factors for their pathology and about exposure to asbestos. For each patient their medical history, their past, recent and current pathology was collected in detail. Information on the workplace and characteristics of their working environment, job description, use and frequency of direct and indirect exposure to asbestos, sources of non-occupational exposure, residential and daily life background was collected. Exposure to asbestos is considered significant only in cases where the latency period is equal to or longer than ten years. Results. From the medical history of the 55 cases, it emerged that 18 had been exposed to asbestos. In 3 cases the patients had been exposed by inhalation in a workplace setting, while in the other 15 cases an exposure linked to a presumable ingestion of asbestos fibres contained in the water collected in domestic asbestos-cement water tanks was postulated. Conclusions. A weak association between tumours of the bile ducts and exposure to asbestos has already been postulated in the past on the basis of studies conducted on cohorts of workers exposed to asbestos. Our analysis also indicates a possible association between exposure to asbestos and neoplasms of the biliary ducts.Downloads
Published
Issue
Section
License
OPEN ACCESS
All the articles of the European Journal of Oncology and Environmental Health are published with open access under the CC-BY Creative Commons attribution license (the current version is CC-BY, version 4.0 http://creativecommons.org/licenses/by/4.0/). This means that the author(s) retain copyright, but the content is free to download, distribute and adapt for commercial or non-commercial purposes, given appropriate attribution to the original article.
The articles in the previous edition of the Journal (European Journal of Oncology) are made available online with open access under the CC-BY Creative Commons attribution license (the current version is CC-BY, version 4.0 http://creativecommons.org/licenses/by/4.0/).
Upon submission, author(s) grant the Journal the license to publish their original unpublished work within one year, and the non exclusive right to display, store, copy and reuse the content. The CC-BY Creative Commons attribution license enables anyone to use the publication freely, given appropriate attribution to the author(s) and citing the Journal as the original publisher. The CC-BY Creative Commons attribution license does not apply to third-party materials that display a copyright notice to prohibit copying. Unless the third-party content is also subject to a CC-BY Creative Commons attribution license, or an equally permissive license, the author(s) must comply with any third-party copyright notices.